Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308295 · ClinicalTrials.gov registry record · NA
A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT00308295 is a NA study that has completed, run by Indiana University. The registered enrollment target is 27 participants.
The verdict
NCT00308295, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The main goal of this study is to determine whether the American Heart Association-recommended fish oil dose is efficacious, safe, and tolerable in hemodialysis patients. The secondary objective is to test the effects of fish oil supplementation on inflammatory and cardiovascular markers.
Interventions
- DRUG Fish oil capsules
- DRUG matched placebo capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2006-04 |
| Est. Completion | 2006-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00308295
The ClinicalTrials.gov registry entry for NCT00308295 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fish oil capsules is the first listed.
NCT00308295 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00308295 about?
NCT00308295 is a clinical study titled "A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients". The main goal of this study is to determine whether the American Heart Association-recommended fish oil dose is efficacious, safe, and tolerable in hemodialysis patients. The secondary objective is to test the effects of fish oil supplementation on inflammatory and cardiovascular markers.
What is the current status of trial NCT00308295?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2006-04. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00308295?
The interventions under investigation include: Fish oil capsules (DRUG), matched placebo capsules (DRUG).
Who is sponsoring clinical trial NCT00308295?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.